ArticleThe international journal of cardiovascular imaging2026
The impact of pericardial disruption on heart function and remodeling after myocardial infarction in mice.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial infarction (MI) remains a leading cause of deaths globally. Thus, reliable and relevant animal MI models are crucial to understand underlying disease mechanisms and develop new therapies. Generally, MI in rodents is induced by ligation of the left anterior descending artery (LAD) leaving a ruptured pericardium. This contrasts MI in man, where the pericardium remains intact. Herein, we therefore determined in adult mice whether pericardial disruption along MI influences left ventricular (LV) heart function, remodeling, and scar formation. Baseline heart function was assessed in 30 C57BL/6J adult, female mice, using state-of-the-art ultra-high-resolution ultrasound imaging (Vevo F2). After one week, MI was randomly introduced by LAD in two groups of mice with or without rupturing the pericardium. Functional heart recovery was evaluated 1- and 10 weeks post-MI, whereas success of MI introduction, animal survival, and scarring were quantified at week 10 by Masson's Trichrome histology and compared between groups. The success of MI introduction as well as mouse survival was equal between groups (p > 0.05). Cohort baseline data revealed normal heart function (55.9 ± 4.5% ejection fraction (EF), 33.3 ± 3.2% fractional shortening (FS), 23.3 ± 4.2 µL end-systolic volume (ESV), 52.5 ± 5.1 µL end-diastolic volume (EDV) and 29.2 ± 2.1 µL stroke volume (SV) (mean, SD, n = 21)). At 1-week post-MI, all mice exhibited significant (all p < 0.05) systolic dysfunction, which persisted at 10-weeks post-MI (46.8 ± 7.4%- vs. 49.3 ± 10.0% EF, 24.7 ± 6.3%- vs. 24.7 ± 5.6% FS, and 35.7 ± 12.8 µL- vs. 37.0 ± 14.9 µL ESV for intact and ruptured pericardium, respectively (mean, SD, n = 9 and 12)) with no major differences between groups (all p > 0.05). For ruptured pericardium, we did see a slight increase in EF and SV from week 1 to 10. Ventricular remodeling was equally evident in both groups, with increased (all p > 0.05) LV mass and end-systolic- and end-diastolic area, but no difference (all p > 0.05) between groups. A mild increase in LV posterior wall thickness was exclusively apparent for ruptured pericardium, whereas anterior wall thickness was similar between groups. In line, infarct size was similar between groups (p > 0.05). Pericardial integrity does not universally alter heart function and scar size following LAD ligation in adult female mice, but may have some previously unnoticed compensatory effects not present after MI in man and that should be considered when modeling MI in the mouse.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.